1L pembrolizumab (pembro) versus chemotherapy (chemo) for choice-of-carboplatin patients with advanced urothelial carcinoma (UC) in KEYNOTE-361.

Date
2021
Author
Oudard, Stephane
Powles, Thomas
Csoszi, Tibor
ÖZGÜROĞLU, Mustafa
Matsubara, Nobuaki
Geczi, Lajos
Cheng, Susanna Y.
Fradet, Yves
Vulsteke, Christof
Morales-Barrera, Rafael
Flechon, Aude
Gunduz, Seyda
Loriot, Yohann
Rodriguez-Vida, Alejo
Mamtani, Ronac
Yu, Evan Y.
Nam, Kijoeng
Imai, Kentaro
Moreno, Blanca Homet
Alva, Ajjai Shivaram
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/172673
https://doi.org/10.1200/jco.2021.39.6_suppl.450
Collections